NASDAQ:MTAC

MedTech Acquisition (MTAC) Stock Forecast, Price & News

$10.45

+0.04 (+0.38%)

(As of 06/2/2023 ET)

Compare

Today's Range: $10.43
▼
$10.45
50-Day Range: $10.19
▼
$10.45
52-Week Range: $9.80
▼
$10.68

Volume: 8,277 shs
Average Volume: 1,337 shs
Market Capitalization: $85.69 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership Headlines SEC Filings Short Interest Social Media

About MedTech Acquisition (NASDAQ:MTAC) Stock

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

Receive MTAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

MTAC Stock News Headlines

May 30, 2023 | msn.com

Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson

May 10, 2023 | investing.com

LAVA Medtech Acquisition Corp (LVAC)

June 3, 2023 | Legacy Research (Affiliate) (Ad)

The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty

A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.

April 26, 2023 | forbes.com

Six Ways To Lead The Charge In Medtech

April 20, 2023 | finance.yahoo.com

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

April 19, 2023 | americanbankingnews.com

MedTech Acquisition (NASDAQ:MTAC) and Elekta AB (publ) (OTCMKTS:EKTAY) Head to Head Survey

April 7, 2023 | americanbankingnews.com

Comparing Akumin (NASDAQ:AKU) & MedTech Acquisition (NASDAQ:MTAC)

February 21, 2023 | finance.yahoo.com

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

June 3, 2023 | Legacy Research (Affiliate) (Ad)

The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty

December 8, 2022 | yahoo.com

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

November 16, 2022 | finance.yahoo.com

TriSalus Goes SPAC Way To Fund Pressure-Enabled Drug Delivery Tech Based Cancer Trials

November 14, 2022 | finance.yahoo.com

TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation

August 9, 2022 | finance.yahoo.com

Global MedTech Healthcare IT Industry Competitive Landscape

July 27, 2022 | apnews.com

LSI Emerging Medtech Summit 2022 Brings Venture Capital and Entrepreneurs Closer in New Event in Europe

July 15, 2022 | benzinga.com

Ophthalmic Devices Market is expected to be worth USD 83.1 billion by 2030, with a CAGR of 4.7%.

June 12, 2022 | seekingalpha.com

Medtronic: Stable Growth Ahead

May 31, 2022 | msn.com

3 Med-Tech Stocks With Incredible Potential

May 27, 2022 | seekingalpha.com

Medtronic plc (MDT) CEO Geoff Martha on Q4 2022 Results - Earnings Call Transcript

April 8, 2022 | finance.yahoo.com

MedTech Acquisition Corporation (MTAC)

March 10, 2022 | seekingalpha.com

SPAC MedTech Acquisition, Memic Innovative Surgery call off planned merger

December 30, 2021 | finance.yahoo.com

A look at the South Florida tech companies that were acquired or went public in 2021

November 13, 2021 | nasdaq.com

MedTech Acquisition Corporation Class A Common Stock (MTAC)

October 7, 2021 | nasdaq.com

How Much Of MedTech Acquisition Corporation (NASDAQ:MTAC) Do Institutions Own?

September 9, 2021 | finance.yahoo.com

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

September 4, 2021 | investing.com

MedTech Acquisition Corp (MTAC)

August 23, 2021 | bizjournals.com

Technology & Innovation Roundup: Memic Innovative Surgery to go public in SPAC merger

August 13, 2021 | markets.businessinsider.com

Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company

See More Headlines

MTAC Price History

30 days | 90 days | 365 days | Advanced Chart

MTAC Company Calendar

Today: 6/03/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MTAC
CUSIP: N/A
CIK: 1826667
Web: N/A
Phone: 908-391-1288
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $5.54 million
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -17.92%
Return on Assets: 1.66%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.06
Quick Ratio: 0.06

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: $0.89 per share
Price / Cash Flow: 11.75
Book Value: ($1.69) per share
Price / Book: -6.18

Miscellaneous

Outstanding Shares: 8,200,000
Free Float: 1,952,000
Market Cap: $85.69 million
Optionable: Not Optionable
Beta: -0.03

Key Executives

Mr. Christopher C. Dewey (Age 79)
CEO & Director

Mr. David J. Matlin J.D. (Age 61)
CFO & Director

Mr. Robert H. Weiss J.D. (Age 64)
Chief Admin. Officer & Sec.

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

MTAC Stock - Frequently Asked Questions

How have MTAC shares performed in 2023?: MedTech Acquisition's stock was trading at $10.03 at the beginning of 2023. Since then, MTAC shares have increased by 4.2% and is now trading at $10.45.
View the best growth stocks for 2023 here.
What is MedTech Acquisition's stock symbol?: MedTech Acquisition trades on the NASDAQ under the ticker symbol "MTAC."
Who are MedTech Acquisition's major shareholders?: MedTech Acquisition's stock is owned by many different institutional and retail investors. Top institutional investors include SkyView Investment Advisors LLC (1.83%), Virtu Financial LLC (0.13%) and Graham Capital Wealth Management LLC (0.08%).

How do I buy shares of MedTech Acquisition?: Shares of MTAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MedTech Acquisition's stock price today?: One share of MTAC stock can currently be purchased for approximately $10.45.
How much money does MedTech Acquisition make?: MedTech Acquisition (NASDAQ:MTAC) has a market capitalization of $85.69 million.
How can I contact MedTech Acquisition?: MedTech Acquisition's mailing address is 1345 AVENUE OF THE AMERICAS, NEW YORK NY, 10105. The company can be reached via phone at 908-391-1288.

This page (NASDAQ:MTAC) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial